⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for laryngeal squamous cell carcinoma

Every month we try and update this database with for laryngeal squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck CancerNCT06084845
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Oral Cavity Squ...
Oropharyngeal S...
Stage III Cutan...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IV Cutane...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Oropha...
Biospecimen Col...
Carboplatin
Chest Radiograp...
Cisplatin
Computed Tomogr...
Image Guided Ra...
Intensity-Modul...
Magnetic Resona...
Positron Emissi...
Xevinapant
18 Years - Eastern Cooperative Oncology Group
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take CisplatinNCT03258554
Clinical Stage ...
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Oral Cavity Squ...
Oropharyngeal S...
Pathologic Stag...
Squamous Cell C...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oroph...
Stage IVB Hypop...
Stage IVB Laryn...
Stage IVB Lip a...
Stage IVB Oroph...
Cetuximab
Durvalumab
Intensity-Modul...
Laboratory Biom...
Quality-of-Life...
Questionnaire A...
18 Years - National Cancer Institute (NCI)
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsNCT05551117
Castration-Resi...
Androgen-Indepe...
Androgen-Insens...
Androgen-Resist...
Hormone Refract...
Anal Cancer
Anal Neoplasm
Carcinoma, Squa...
Head and Neck S...
Laryngeal Squam...
Oral Squamous C...
Malignant Melan...
Melanoma
Non-small Cell ...
Non-small Cell ...
Small-cell Lung...
Small Cell Carc...
vobramitamab du...
vobramitamab du...
vobramitamab du...
18 Years - MacroGenics
Validation of a Screening Tool in Geriatric OncologyNCT00963911
Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Lymphoma
Prostate Cancer
Geriatric scree...
Multidimensiona...
70 Years - 120 YearsInstitut Bergonié
Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.NCT05333523
Laryngeal Squam...
Hypopharynx Squ...
Oropharyngeal S...
Sentinel lymph ...
Standard electi...
18 Years - Radboud University Medical Center
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.NCT05832593
Laryngeal Squam...
Immunohistochem...
- Assiut University
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyNCT05136196
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Lip and Oral Ca...
Melanoma
Oropharyngeal S...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Oropha...
Biopsy
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryNCT02734537
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Laryngeal Squam...
Lip and Oral Ca...
p16INK4a Negati...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oral ...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oral ...
Stage IVA Oroph...
Cisplatin
Intensity-Modul...
Laboratory Biom...
18 Years - Eastern Cooperative Oncology Group
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyNCT05136196
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Lip and Oral Ca...
Melanoma
Oropharyngeal S...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oroph...
Stage IV Hypoph...
Stage IV Laryng...
Stage IV Lip an...
Stage IV Oropha...
Biopsy
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]NCT06137378
Squamous Cell C...
Hypopharyngeal ...
Laryngeal Squam...
Laryngeal Squam...
Squamous Cell C...
Squamous Cell C...
Squamous Cell C...
Squamous Cell C...
Laryngeal Squam...
Laryngectomy; S...
Laryngeal Cance...
Laryngeal Neopl...
KEYTRUDA®
18 Years - 70 YearsUniversity of Leipzig
Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.NCT05832593
Laryngeal Squam...
Immunohistochem...
- Assiut University
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsNCT05551117
Castration-Resi...
Androgen-Indepe...
Androgen-Insens...
Androgen-Resist...
Hormone Refract...
Anal Cancer
Anal Neoplasm
Carcinoma, Squa...
Head and Neck S...
Laryngeal Squam...
Oral Squamous C...
Malignant Melan...
Melanoma
Non-small Cell ...
Non-small Cell ...
Small-cell Lung...
Small Cell Carc...
vobramitamab du...
vobramitamab du...
vobramitamab du...
18 Years - MacroGenics
IMP3 and PCNA Expression in Laryngeal Squamous Cell Carcinoma in Sohag GovernorateNCT05293327
Laryngeal Squam...
- Sohag University
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without ChemotherapyNCT02582008
Current Smoker
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Nasopharyngeal ...
Oral Cavity Squ...
Oropharyngeal S...
Bupropion Hydro...
Laboratory Biom...
Nicotine Replac...
Quality-of-Life...
Questionnaire A...
Varenicline
18 Years - Wake Forest University Health Sciences
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryNCT02734537
Head and Neck S...
Hypopharyngeal ...
Laryngeal Squam...
Laryngeal Squam...
Lip and Oral Ca...
p16INK4a Negati...
Stage III Hypop...
Stage III Laryn...
Stage III Lip a...
Stage III Oral ...
Stage III Oroph...
Stage IVA Hypop...
Stage IVA Laryn...
Stage IVA Lip a...
Stage IVA Oral ...
Stage IVA Oroph...
Cisplatin
Intensity-Modul...
Laboratory Biom...
18 Years - Eastern Cooperative Oncology Group
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: